These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 17845756)
1. [Protein overexpression and gene copy number of EGFR and HER2 in colorectal carcinoma]. Zeng X; Wang P; Wu SF; Gao J; Liang ZY; Liu TH Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):447-52. PubMed ID: 17845756 [TBL] [Abstract][Full Text] [Related]
2. Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients. Liang Z; Zeng X; Gao J; Wu S; Wang P; Shi X; Zhang J; Liu T BMC Cancer; 2008 Dec; 8():363. PubMed ID: 19061514 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression]. Zeng X; Liang ZY; Wu SF; Zhou WX; Gao J; Liu TH Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563 [TBL] [Abstract][Full Text] [Related]
4. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target. Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290 [TBL] [Abstract][Full Text] [Related]
5. [HER2 status in breast cancer of Chinese women: a study of 1170 cases using fluorescence in-situ hybridization]. Zeng X; Liang ZY; Wu SF; Gao J; Zhou WX; Liu TH Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):594-8. PubMed ID: 19094582 [TBL] [Abstract][Full Text] [Related]
6. [EGFR and HER2 gene expression status and their correlation in non-small cell lung cancer]. Zeng X; Wu SF; Zhou WX; Li DJ; Gao J; Liang ZY; Liu TH Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):398-402. PubMed ID: 17069674 [TBL] [Abstract][Full Text] [Related]
7. Effect of high copy number of HER2 associated with polysomy 17 on HER2 protein expression in invasive breast carcinoma. Shah SS; Wang Y; Tull J; Zhang S Diagn Mol Pathol; 2009 Mar; 18(1):30-3. PubMed ID: 19214111 [TBL] [Abstract][Full Text] [Related]
8. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas. Suzuki S; Dobashi Y; Minato H; Tajiri R; Yoshizaki T; Ooi A Virchows Arch; 2012 Sep; 461(3):271-82. PubMed ID: 22828828 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study. Koutras A; Lazaridis G; Koliou GA; Kouvatseas G; Christodoulou C; Pectasides D; Kotoula V; Batistatou A; Bobos M; Tsolaki E; Papadopoulou K; Pentheroudakis G; Papakostas P; Pervana S; Petraki K; Chrisafi S; Razis E; Psyrri A; Bafaloukos D; Kalogeras KT; Kalofonos HP; Fountzilas G PLoS One; 2018; 13(12):e0207707. PubMed ID: 30521571 [TBL] [Abstract][Full Text] [Related]
10. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma. Sholl LM; John Iafrate A; Chou YP; Wu MT; Goan YG; Su L; Huang YT; Christiani DC; Chirieac LR Mod Pathol; 2007 Oct; 20(10):1028-35. PubMed ID: 17673923 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer. Jeon YK; Sung SW; Chung JH; Park WS; Seo JW; Kim CW; Chung DH Lung Cancer; 2006 Dec; 54(3):387-98. PubMed ID: 17011067 [TBL] [Abstract][Full Text] [Related]
12. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma. Yoshida H; Yamamoto N; Taniguchi H; Oda I; Katai H; Kushima R; Tsuda H Virchows Arch; 2014 Aug; 465(2):145-54. PubMed ID: 24889042 [TBL] [Abstract][Full Text] [Related]
13. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations. Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676 [TBL] [Abstract][Full Text] [Related]
14. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer. Simone G; Mangia A; Malfettone A; Rubini V; Siciliano M; Di Benedetto A; Terrenato I; Novelli F; Mottolese M J Exp Clin Cancer Res; 2010 Sep; 29(1):125. PubMed ID: 20843314 [TBL] [Abstract][Full Text] [Related]
15. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis. Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363 [TBL] [Abstract][Full Text] [Related]
16. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Bhargava R; Gerald WL; Li AR; Pan Q; Lal P; Ladanyi M; Chen B Mod Pathol; 2005 Aug; 18(8):1027-33. PubMed ID: 15920544 [TBL] [Abstract][Full Text] [Related]
17. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17. Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884 [TBL] [Abstract][Full Text] [Related]
18. HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients. Martin V; Landi L; Molinari F; Fountzilas G; Geva R; Riva A; Saletti P; De Dosso S; Spitale A; Tejpar S; Kalogeras KT; Mazzucchelli L; Frattini M; Cappuzzo F Br J Cancer; 2013 Feb; 108(3):668-75. PubMed ID: 23348520 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer. Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718 [TBL] [Abstract][Full Text] [Related]